News
Cardinal Health builds out urology focus with $1.9B deal for Solaris Health
Cardinal Health acquired Solaris Health as it continues to build out its multispecialty management services organization platform. | Cardinal Health MSO platforms will reach about 3,000 providers in 32 states once the Solaris Health deal closes,
16h
Cardinal Health's $1.9 Billion Urology Bet Sends Shares Sliding -- But Could Spark Long-Term Growth
Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...
Cardinal Health will acquire Solaris Health for $1.9 billion, lifting its specialty platform while posting mixed Q4 results ...
Cardinal Health reported revenue of $1.6 billion in the fourth quarter for its Other segment, which includes at-Home ...
Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty ...
Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...
Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization ...
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback